Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 12, 2022

SELL
$219.27 - $242.57 $124,983 - $138,264
-570 Closed
0 $0
Q4 2021

Jan 18, 2022

SELL
$198.88 - $227.6 $422,620 - $483,650
-2,125 Reduced 78.85%
570 $128,000
Q3 2021

Oct 18, 2021

BUY
$212.27 - $248.7 $572,067 - $670,246
2,695 New
2,695 $573,000
Q1 2021

Apr 09, 2021

SELL
$221.91 - $258.6 $365,707 - $426,172
-1,648 Closed
0 $0
Q4 2020

Jan 11, 2021

BUY
$216.38 - $257.67 $351,184 - $418,198
1,623 Added 6492.0%
1,648 $379,000
Q3 2020

Oct 23, 2020

SELL
$234.65 - $260.95 $478,920 - $532,598
-2,041 Reduced 98.79%
25 $6,000
Q2 2020

Jul 13, 2020

BUY
$197.81 - $242.74 $174,072 - $213,611
880 Added 74.2%
2,066 $462,000
Q1 2020

Apr 14, 2020

SELL
$182.24 - $241.7 $65,606 - $87,012
-360 Reduced 23.29%
1,186 $240,000
Q4 2019

Jan 31, 2020

SELL
$189.21 - $243.2 $1.37 Million - $1.76 Million
-7,235 Reduced 82.39%
1,546 $372,000
Q3 2019

Oct 15, 2019

BUY
$174.11 - $208.62 $1.52 Million - $1.83 Million
8,751 Added 29170.0%
8,781 $1.7 Million
Q2 2019

Jul 18, 2019

SELL
$166.7 - $195.41 $469,093 - $549,883
-2,814 Reduced 98.95%
30 $6,000
Q1 2019

Apr 11, 2019

BUY
$180.87 - $203.88 $498,839 - $562,301
2,758 Added 3206.98%
2,844 $541,000
Q4 2018

Jan 22, 2019

BUY
$178.4 - $208.25 $14,093 - $16,451
79 Added 1128.57%
86 $17,000
Q3 2018

Oct 23, 2018

SELL
$185.29 - $208.89 $28,719 - $32,377
-155 Reduced 95.68%
7 $1,000
Q2 2018

Aug 01, 2018

SELL
$166.05 - $186.51 $388,224 - $436,060
-2,338 Reduced 93.52%
162 $30,000
Q1 2018

May 02, 2018

SELL
$169.43 - $198.0 $437,298 - $511,038
-2,581 Reduced 50.8%
2,500 $427,000
Q4 2017

Feb 07, 2018

BUY
$168.79 - $188.59 $857,621 - $958,225
5,081
5,081 $884,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Nu Wave Investment Management, LLC Portfolio

Follow Nu Wave Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nu Wave Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nu Wave Investment Management, LLC with notifications on news.